Upregulation of heat shock proteins and the promotion of damage-associated molecular pattern signals in a colorectal cancer model by modulated electrohyperthermia

Cell Stress and Chaperones

Volumn 20, Issue 1, 2015, Pages 37-46

  Andocs, Gabor ^a   Meggyeshazi, Nora ^b   Balogh, Lajos ^c   Spisak, Sandor ^d   Maros, Mate Elod ^b   Balla, Peter ^b   Kiszner, Gergo ^b   Teleki, Ivett ^b   Kovago, Csaba ^e   Krenacs, Tibor ^b,d  

^a UNIVERSITY OF TOYAMA   (Japan)

^b SEMMELWEIS UNIVERSITY   (Hungary)

^c National Research Institute for Radiobiology and Radiohygiene Budapest   (Hungary)

^d INSTITUTE OF EXPERIMENTAL MEDICINE   (Hungary)

^e SZENT ISTVÁN UNIVERSITY   (Hungary)

Author keywords

Calreticulin; Damage associated molecular pattern; Heat shock protein; High mobility group box1 protein; Modulated electrohyperthermia

Indexed keywords

CALRETICULIN; HEAT SHOCK PROTEIN 70; HEAT SHOCK PROTEIN 90; HIGH MOBILITY GROUP B1 PROTEIN; MESSENGER RNA;

ANIMAL; BAGG ALBINO MOUSE; COLORECTAL TUMOR; FLUORESCENT ANTIBODY TECHNIQUE; GENETICS; HT 29 CELL LINE; HUMAN; HYPERTHERMIC THERAPY; METABOLISM; NUDE MOUSE; PATHOPHYSIOLOGY; UPREGULATION; XENOGRAFT;

ANIMALS; CALRETICULIN; COLORECTAL NEOPLASMS; FLUORESCENT ANTIBODY TECHNIQUE; HMGB1 PROTEIN; HSP70 HEAT-SHOCK PROTEINS; HSP90 HEAT-SHOCK PROTEINS; HT29 CELLS; HUMANS; HYPERTHERMIA, INDUCED; MICE, INBRED BALB C; MICE, NUDE; RNA, MESSENGER; TRANSPLANTATION, HETEROLOGOUS; UP-REGULATION;

EID: 84914672760     PISSN: 13558145     EISSN: 14661268     Source Type: Journal    
DOI: 10.1007/s12192-014-0523-6     Document Type: Article

References (43)

1. Andocs G, Renner H, Balogh L, Fonyad L, Jakab C, Szasz A (2009a) Strong synergy of heat and modulated electromagnetic field in tumor cell killing. Strahlenther Onkol Organ Dtsch Rontgengesellschaft 185:120–126. doi:10.1007/s00066-009-1903-1
2. Andocs G, Szasz O, Szasz A (2009b) Oncothermia treatment of cancer: from the laboratory to clinic. Electromagn Biol Med 28:148–165. doi:10.1080/15368370902724633
3. Balogh G et al (2013) Key role of lipids in heat stress management. FEBS Lett 587:1970–1980. doi:10.1016/j.febslet.2013.05.016
4. Blad B, Baldetorp B (1996) Impedance spectra of tumour tissue in comparison with normal tissue. A possible clinical application for electrical impedance tomography. Physiol Meas 17:A105–A115. doi:10.1088/0967-3334/17/4a/015
5. Blad B, Wendel P, Jonsson M, Lindstrom K (1999) An electrical impedance index to distinguish between normal and cancerous tissues. J Med Eng Technol 23:57–62. doi:10.1080/030919099294294
6. Blank M, Goodman R (2009) Electromagnetic fields stress living cells. Pathophysiol Off J Int Soc Pathophysiol/ISP 16:71–78. doi:10.1016/j.pathophys.2009.01.006
7. Brazma A et al (2001) Minimum information about a microarray experiment (MIAME)—toward standards for microarray data. Nat Genet 29:365–371
8. Calderwood SK, Mambula SS, Gray PJ Jr (2007) Extracellular heat shock proteins in cell signaling and immunity. Ann N Y Acad Sci 1113:28–39. doi:10.1196/annals.1391.019
9. Castano AP, Mroz P, Hamblin MR (2006) Photodynamic therapy and anti-tumour immunity. Nat Rev Cancer 6:535–545. doi:10.1038/nrc1894
10. D’Eliseo D, Manzi L, Velotti F (2013) Capsaicin as an inducer of damage-associated molecular patterns (DAMPs) of immunogenic cell death (ICD) in human bladder cancer cells. Cell Stress Chaperones. doi:10.1007/s12192-013-0422-2
11. Feyerabend T, Wiedemann GJ, Jager B, Vesely H, Mahlmann B, Richter E (2001) Local hyperthermia, radiation, and chemotherapy in recurrent breast cancer is feasible and effective except for inflammatory disease. Int J Radiat Oncol Biol Phys 49:1317–1325
12. Fiorentini G, Szasz A (2006) Hyperthermia today: electric energy, a new opportunity in cancer treatment. J Cancer Res Ther 2:41–46
13. Fiorentini G, Giovanis P, Rossi S, Dentico P, Paola R, Turrisi G, Bernardeschi P (2006) A phase II clinical study on relapsed malignant gliomas treated with electro-hyperthermia. In vivo (Athens, Greece) 20:721–724
14. Frey B et al (2012) Old and new facts about hyperthermia-induced modulations of the immune system. Int J Hyperther Off J Eur Soc Hyperther Oncol N Am Hyperther Group 28:528–542. doi:10.3109/02656736.2012.677933
15. Garg AD, Nowis D, Golab J, Vandenabeele P, Krysko DV, Agostinis P (2010) Immunogenic cell death, DAMPs and anticancer therapeutics: an emerging amalgamation. Biochim Biophys Acta 1805:53–71. doi:10.1016/j.bbcan.2009.08.003
16. Garg AD, Krysko DV, Vandenabeele P, Agostinis P (2012) Hypericin-based photodynamic therapy induces surface exposure of damage-associated molecular patterns like HSP70 and calreticulin. Cancer Immunol Immunother CII 61:215–221
17. Garg AD, Martin S, Golab J, Agostinis P (2013) Danger signalling during cancer cell death: origins, plasticity and regulation. Cell Death Differ. doi:10.1038/cdd.2013.48
18. Gehrmann M, Radons J, Molls M, Multhoff G (2008) The therapeutic implications of clinically applied modifiers of heat shock protein 70 (Hsp70) expression by tumor cells. Cell Stress Chaperones 13:1–10. doi:10.1007/s12192-007-0006-0
19. Guo ZS, Liu Z, Bartlett DL, Tang D, Lotze MT (2013) Life after death: targeting high mobility group box 1 in emergent cancer therapies. Am J Cancer Res 3:1–20
20. Hager ED, Dziambor H, Hohmann D, Gallenbeck D, Stephan M, Popa C (1999) Deep hyperthermia with radiofrequencies in patients with liver metastases from colorectal cancer. Anticancer Res 19:3403–3408
21. Horvath I, Vigh L (2010) Cell biology: stability in times of stress. Nature 463:436–438. doi:10.1038/463436a
22. Kepp O, Tesniere A, Schlemmer F, Michaud M, Senovilla L, Zitvogel L, Kroemer G (2009) Immunogenic cell death modalities and their impact on cancer treatment. Apoptosis Int J Program Cell Death 14:364–375. doi:10.1007/s10495-008-0303-9
23. Kepp O et al (2011) Molecular determinants of immunogenic cell death elicited by anticancer chemotherapy. Cancer Metastasis Rev 30:61–69. doi:10.1007/s10555-011-9273-4
24. Kroemer G, Galluzzi L, Kepp O, Zitvogel L (2013) Immunogenic cell death in cancer therapy. Annu Rev Immunol 31:51–72. doi:10.1146/annurev-immunol-032712-100008
25. Krysko O, Love Aaes T, Bachert C, Vandenabeele P, Krysko DV (2013) Many faces of DAMPs in cancer therapy. Cell Death Dis 4:e631. doi:10.1038/cddis.2013.156
26. Ladoire S et al (2013) Cell-death-associated molecular patterns as determinants of cancer immunogenicity. Antioxid Redox Signal. doi:10.1089/ars.2012.5133
27. Mace TA, Zhong L, Kokolus KM, Repasky EA (2012) Effector CD8+ T cell IFN-gamma production and cytotoxicity are enhanced by mild hyperthermia. Int J Hyperther Off J Eur Soc Hyperther Oncol N Am Hyperther Group 28:9–18. doi:10.3109/02656736.2011.616182
28. Mantel F et al (2010) Combination of ionising irradiation and hyperthermia activates programmed apoptotic and necrotic cell death pathways in human colorectal carcinoma cells. Strahlenther Onkol Organ Dtsch Rontgengesellschaft 186:587–599. doi:10.1007/s00066-010-2154-x
29. Martins I et al (2012) Premortem autophagy determines the immunogenicity of chemotherapy-induced cancer cell death. Autophagy 8:413–415. doi:10.4161/auto.19009
30. Meggyeshazi N et al (2014) DNA fragmentation and caspase-independent programmed cell death by modulated electrohyperthermia. Strahlenther Onkol Organ Dtsch Rontgengesellschaft. doi:10.1007/s00066-014-0617-1
31. Menger L et al (2012) Cardiac glycosides exert anticancer effects by inducing immunogenic cell death. Sci Transl Med 4:143ra199. doi:10.1126/scitranslmed.3003807
32. Mroz P, Hashmi JT, Huang YY, Lange N, Hamblin MR (2011) Stimulation of anti-tumor immunity by photodynamic therapy. Expert Rev Clin Immunol 7:75–91. doi:10.1586/eci.10.81
33. Multhoff G, Hightower LE (2011) Distinguishing integral and receptor-bound heat shock protein 70 (Hsp70) on the cell surface by Hsp70-specific antibodies. Cell Stress Chaperones 16:251–255. doi:10.1007/s12192-010-0247-1
34. Multhoff G, Gaipl US, Niedermann G (2012) The role of radiotherapy in the induction of antitumor immune responses. Strahlenther Onkol Organ Dtsch Rontgengesellschaft 188(Suppl 3):312–315. doi:10.1007/s00066-012-0206-0
35. Obeid M et al (2007) Calreticulin exposure dictates the immunogenicity of cancer cell death. Nat Med 13:54–61. doi:10.1038/nm1523
36. Pfister K et al (2007) Patient survival by Hsp70 membrane phenotype: association with different routes of metastasis. Cancer 110:926–935
37. Robert J (2003) Evolution of heat shock protein and immunity. Dev Comp Immunol 27:449–464. doi:10.1016/S0145-305X(02)00160-X
38. Sachamitr P, Fairchild PJ (2012) Cross presentation of antigen by dendritic cells: mechanisms and implications for immunotherapy. Expert Rev Clin Immunol 8:547–555. doi:10.1586/eci.12.45
39. Scheffer SR et al (2003) Apoptotic, but not necrotic, tumor cell vaccines induce a potent immune response in vivo. Int J Cancer 103:205–211. doi:10.1002/ijc.10777
40. Schildkopf P et al (2010) Application of hyperthermia in addition to ionizing irradiation fosters necrotic cell death and HMGB1 release of colorectal tumor cells. Biochem Biophys Res Commun 391:1014–1020
41. Tesniere A et al (2010) Immunogenic death of colon cancer cells treated with oxaliplatin. Oncogene 29:482–491. doi:10.1038/onc.2009.356
42. Ullrich E, Bonmort M, Mignot G, Kroemer G, Zitvogel L (2008) Tumor stress, cell death and the ensuing immune response. Cell Death Differ 15:21–28
43. Zou Y, Guo Z (2003) A review of electrical impedance techniques for breast cancer detection. Med Eng Phys 25:79–90. doi:10.1016/s1350-4533(02)00194-7